Andrea E. DeBarber
Impact in
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology
-
- Hormonal Regulation and Hypertension
- Thyroid Disorders and Treatments
Papers in
- Oncology 19
- Drug Transport and Resistance Mechanisms 17
-
- Metabolism and Genetic Disorders 3
- Co-authors
- Robert D. SteinerClifton E. BarryLouise S. MerkensDennis R. KoopKhisimuzi MdluliM BosmanLinda‐Gail BekkerThomas S. Scanlan
- Journals
- Journal of Lipid Research (5 papers)Journal of clinical lipidology (4 papers)Genetics in Medicine (3 papers)Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2 papers)JAMA Ophthalmology (2 papers)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Andrea E. DeBarber
48 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 103
- Biochemistry 301
- Endocrinology, Diabetes and Metabolism 372
- Infectious Diseases 244
- Pharmacology 114
- Molecular Biology 777
Countries citing papers authored by Andrea E. DeBarber
This map shows the geographic impact of Andrea E. DeBarber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea E. DeBarber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea E. DeBarber more than expected).
Fields of papers citing papers by Andrea E. DeBarber
This network shows the impact of papers produced by Andrea E. DeBarber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea E. DeBarber. The network helps show where Andrea E. DeBarber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrea E. DeBarber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 31 | |
| 7 | 2021 | 11 | |
| 8 | 2020 | 21 | |
| 9 | 2018 | 12 | |
| 10 | 2018 | 23 | |
| 11 | 2018 | 85 | |
| 12 | 2017 | 12 | |
| 13 | 2017 | 25 | |
| 14 | 2016 | 15 | |
| 15 | 2011 | 8 | |
| 16 | 2010 | 33 | |
| 17 | 2009 | 7 | |
| 18 | 2008 | 45 | |
| 19 | 2007 | 107 | |
| 20 | 2004 | 30 |
About Andrea E. DeBarber
Andrea E. DeBarber is a scholar working on Oncology, Clinical Biochemistry, Surgery, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 49 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (24 papers), Drug Transport and Resistance Mechanisms (17 papers), Hormonal Regulation and Hypertension (5 papers), Steroid Chemistry and Biochemistry (4 papers), Metabolism and Genetic Disorders (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). The work is most often cited by research in Biochemistry (301 citations), Endocrinology, Diabetes and Metabolism (372 citations), Infectious Diseases (244 citations), Pharmacology (114 citations) and Molecular Biology (777 citations). Andrea E. DeBarber has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Robert D. Steiner, Clifton E. Barry, Louise S. Merkens, Dennis R. Koop, Khisimuzi Mdluli, M Bosman, Linda‐Gail Bekker, Thomas S. Scanlan, Nabil J. Alkayed and Anuradha S. Pappu. Their work appears in journals such as Journal of Lipid Research, Journal of clinical lipidology, Genetics in Medicine, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids and JAMA Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.